publication venue for
- Effect of vitamin D3 and calcium carbonate supplementation on muscle strength in postmenopausal women living with HIV.. 25. 2020
- Carotid magnetic resonance imaging in persons living with HIV and 10-year atherosclerotic cardiovascular disease risk score.. 23. 2018
- Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial.. 22. 2016
- Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.. 22. 2016
- The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.. 21. 2014
- Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial.. 19. 2013
- Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease.. 18. 2012
- ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection.. 18. 2012
- Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial.. 18. 2012
- Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy.. 18. 2012
- Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.. 17. 2012
- Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.. 16. 2011
- Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study.. 15. 2010
- Oxidant stress in HIV-infected women from the Women's Interagency HIV Study.. 14. 2009
- Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men.. 13. 2008
- Design issues in initial HIV-treatment trials: focus on ACTG A5095.. 11. 2006
- Changes in mitochondrial RNA production in cells treated with nucleoside analogues.. 10. 2005
- Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy.. 7. 2002
- Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.. 4. 1999
- Factors impacting the provision of antiretroviral therapy to people living with HIV: the view from Haiti. 2014
- The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir. 2012